Use of Ginsenoside M1 for preventing or treating gout
US10124017B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2016 |
| Grant date | Nov 13, 2018 |
| Priority date | — |
| Expiry date | Mar 17, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses a new use of ginsenoside M1 for treating or preventing gout.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.